7QN-17134-62775
5 vaccinations
9 coded responses
59 check-ins
9 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 610 / IL
- Registered
- 2021-02-26
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-25
Dose 1 — Moderna
-
2021-02-26
Registered in v-safe
-
2021-02-26
Survey response — days 1–6 daily, dose 1MedDRA: Bell's palsy — Feeling: Good · Site: Pain · Fever · Headache, Rash, not including the immediate area around the injection siteFree text: Bells Palsy type symptomsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-27
- 2021-02-28
- 2021-03-01
- 2021-03-02
- 2021-03-03
- 2021-03-04
- 2021-03-11
- 2021-03-18
- 2021-03-25
-
2021-03-26
Dose 2 — Moderna
- 2021-03-26
- 2021-03-27
- 2021-03-28
- 2021-03-29
- 2021-03-30
- 2021-03-31
- 2021-04-01
- 2021-04-02
- 2021-04-09
- 2021-04-16
- 2021-04-23
- 2021-04-30
- 2021-05-07
- 2021-06-25
- 2021-09-24
-
2021-11-01
Dose 3 — Moderna
-
2021-11-02
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Chills, Joint pains, Muscle or body achesAdult check-in
-
2021-11-03
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-11-04
- 2021-11-05
-
2021-11-06
Survey response — days 1–6 daily, dose 3MedDRA: Injection site discomfort — Feeling: GoodFree text: Just soreness at injection site, not painMedDRA releases: 2024-11 · check-in free text available
-
2021-11-07
Survey response — days 1–6 daily, dose 3MedDRA: No adverse event — Feeling: GoodFree text: NoneMedDRA releases: 2024-11 · check-in free text available
-
2021-11-08
Survey response — day 7, dose 3MedDRA: No adverse event — Feeling: GoodFree text: NoneMedDRA releases: 2024-11 · check-in free text available
- 2021-11-15
- 2021-11-22
- 2021-11-29
- 2021-12-06
- 2021-12-13
- 2022-01-31
-
2022-05-02
Survey response — 6 months, dose 3MedDRA: Pre-existing disease, Tachycardia — Feeling: Good · Be unable to do your normal daily activitiesFree text: Exacerbation of my SVT I'm scheduled for a second Covid vaccine booster injection this FridayMedDRA releases: 2024-11 · check-in free text available
-
2022-05-06
Dose 4 — Moderna
- 2022-05-06
- 2022-05-07
- 2022-05-08
- 2022-05-09
- 2022-05-10
- 2022-05-11
- 2022-05-12
- 2022-05-13
-
2022-05-20
Survey response — day 14, dose 4MedDRA: Atrial fibrillation, Cardioversion — Feeling: Good · Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Cardio version for onset of atrial fibrillation 5/15/2022MedDRA releases: 2024-11 · check-in free text available
-
2022-05-20
Report sent to call center — day 14, dose 4Get care from a doctor or other healthcare professionalEmergency room or emergency department visit · 1 call case(s)
- 2022-05-23
-
2022-05-25
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-05-27
- 2022-06-03
- 2022-06-10
- 2022-06-17
- 2022-08-05
-
2022-09-28
Dose 5 — Moderna
-
2022-10-21
Survey response — day 21, dose 5MedDRA: Cough, Nasopharyngitis, Respiratory tract congestion, Rhinorrhoea — Feeling: FairFree text: Cold symptoms: cough, runny nose, congestion at the end of a 15 day Eastern European river cruise. (October 6 through October 21). No fever.MedDRA releases: 2024-11 · check-in free text available
-
2022-10-26
Survey response — day 28, dose 5MedDRA: Ageusia, Anosmia, Cough, Laryngitis, Nasal congestion, SARS-CoV-2 test positive, Wheezing — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Positive home Covid-19 test Friday October 21 Cough, wheezes, laryngitis, loss of taste and smell, extreme nasal congestion, no feverMedDRA releases: 2024-11 · check-in free text available
-
2022-10-26
Report sent to call center — day 28, dose 5Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-10-28
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-11-02
-
2022-11-09
Survey response — day 42, dose 5MedDRA: Ageusia, Anosmia, Cough, Laryngitis, Nasal congestion, SARS-CoV-2 test negative, SARS-CoV-2 test positive — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Laryngitis going on 3 weeks now. Cough has subsided, nasal congestion is gone, taste and smell have returned (positive Covid-19 test 10/21, negative test on 10/31)MedDRA releases: 2024-11 · check-in free text available
-
2022-11-09
Report sent to call center — day 42, dose 5Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-11-10
- 2022-12-28
- 2023-03-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-25 | Moderna | |
| 2 | 2021-03-26 | Moderna | |
| 3 | 2021-11-01 | Moderna | No |
| 4 | 2022-05-06 | Moderna | No |
| 5 | 2022-09-28 | Moderna | No |
Call center
3 call center cases
2 successful · 1 unsuccessful
Free text
Release 4 — days 1–6 daily, dose 1
Systemic reaction (other): Bells Palsy type symptoms
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Just soreness at injection site, not pain
Systemic reaction (other): None
Release 10 — day 7, dose 3
Systemic reaction (other): None
Release 11 — 6 months, dose 3
Symptoms: Exacerbation of my SVT I'm scheduled for a second Covid vaccine booster injection this Friday
Release 11 — day 14, dose 4
Symptoms: Cardio version for onset of atrial fibrillation 5/15/2022
Release 12 — day 21, dose 5
Symptoms: Cold symptoms: cough, runny nose, congestion at the end of a 15 day Eastern European river cruise. (October 6 through October 21). No fever.
Release 12 — day 28, dose 5
Symptoms: Positive home Covid-19 test Friday October 21 Cough, wheezes, laryngitis, loss of taste and smell, extreme nasal congestion, no fever
Release 12 — day 42, dose 5
Symptoms: Laryngitis going on 3 weeks now. Cough has subsided, nasal congestion is gone, taste and smell have returned (positive Covid-19 test 10/21, negative test on 10/31)
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Ageusia | · | · | ✓ |
| SD | Anosmia | · | · | ✓ |
| SD | Atrial fibrillation | · | · | ✓ |
| SD | Cardioversion | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Laryngitis | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Tachycardia | · | · | ✓ |
| SD | Wheezing | · | · | ✓ |
| SRO | Bell's palsy | ✓ | ✓ | ✓ |
| SRO | Injection site discomfort | · | · | ✓ |
| SRO | No adverse event | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release